Long-term prognosis of autoimmune pancreatitis in terms of glucose tolerance

Pancreas

Volumn 41, Issue 5, 2012, Pages 691-695

  Hirano, Kenji ^a   Isogawa, Akihiro ^b   Tada, Minoru ^a   Isayama, Hiroyuki ^a   Takahara, Naminatsu ^a   Miyabayashi, Koji ^a   Mizuno, Suguru ^a   Mohri, Dai ^a   Kawakubo, Kazumichi ^a   Sasaki, Takashi ^a   Kogure, Hirofumi ^a   Yamamoto, Natsuyo ^a   Sasahira, Naoki ^a   Toda, Nobuo ^b   Nagano, Rie ^c   Yagioka, Hiroshi ^d   Yashima, Yoko ^e   Hamada, Tsuyoshi ^e   Ito, Yukiko ^e   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b MITSUI MEMORIAL HOSPITAL   (Japan)

^c The Mutualaid Association of Public School Teachers)   (Japan)

^d JR Tokyo General Hospital   (Japan)

^e JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

Autoimmune pancreatitis; Diabetes mellitus; Glucose tolerance; Steroid

Indexed keywords

ANTIDIABETIC AGENT; C PEPTIDE; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN; STEROID;

ADULT; AGED; ARTICLE; AUTOIMMUNE PANCREATITIS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GLUCAGON BLOOD LEVEL; GLUCAGON TOLERANCE TEST; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN TREATMENT; LONG TERM CARE; MALE; NUTRITIONAL TOLERANCE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AUTOIMMUNE DISEASES; BLOOD GLUCOSE; DIABETES COMPLICATIONS; FEMALE; GLUCOCORTICOIDS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PANCREATITIS; PROGNOSIS; TIME FACTORS;

EID: 84863717074     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31823bcdee     Document Type: Article

References (25)

1. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352-358.
2. Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol. 2008;43:403-408.
3. Klöppel G, Lüttges J, Löhr M, Zamboni G, et al. Autoimmune pancreatitis: pathological, clinical, and immunological features. Pancreas. 2003;27:14-19.
4. Hirano K, Fukushima N, Tada M, et al. Diagnostic utility of biopsy specimens for autoimmune pancreatitis. J Gastroenterol. 2009;44:765-773.
5. Hirano K, Shiratori Y, Komatsu Y, et al. An involvement of the biliary system in autoimmune pancreatitis: a follow-up study. Clin Gastroenterol Hepatol. 2003;1:453-464.
6. Hirano K, Tada M, Isayama H, et al. Endoscopic evaluation of factors contributing to intrapancreatic biliary stricture in autoimmune pancreatitis. Gastrointest Endosc. 2010;71:85-90.
7. Hirano K, Kawabe T, Komatsu Y, et al. High-rate pulmonary involvement in autoimmune pancreatitis. Intern Med J. 2006;36:58-61.
8. Nishi H, Tojo A, Onozato ML, et al. Anti-carbonic anhydrase II antibody in autoimmune pancreatitis and tubulointerstitial nephritis. Nephrol Dial Transplant. 2007;22:1273-1275.
9. Hirano K, Tada M, Isayama H, et al. Long-term prognosis of autoimmune pancreatitis without and with corticosteroid treatment. Gut. 2007;56:1719-1724.
10. Ito T, Kawabe K, Arita Y, et al. Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis. Pancreas. 2007;34:254-259.
11. Nishimori I, Tamakoshi A, Kawa S, et al. Research Committee on Intractable Pancreatic Diseases, the Ministry of Health and Welfare of Japan. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan. Pancreas. 2006;32:244-248.
12. Nishino T, Toki F, Oyama H, et al. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med. 2006;45:497-501.
13. Kamisawa T, Yoshiike M, Egawa N, et al. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology. 2005;5:234-238.
14. Ito T, Nishimori I, Inoue N, et al. Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol. 2007;42(suppl 180):50-58.
15. Vague P, Nguyen L. Rationale and methods for the estimation of insulin secretion in a given patient: from research to clinical practice. Diabetes. 2002;51(suppl 1):S240-S244.
16. Prando R, Odetti P, Melga P, et al. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency. Diabetes Metab. 1996;22:185-191.
17. Weinstein SP, Wilson CM, Pritsker A, et al. Dexamethasone inhibits insulin-stimulated recruitment of GLUT4 to the cell surface in rat skeletal muscle. Metabolism. 1998;47:3-6.
18. Dimitriadis G, Leighton B, Parry-Billings M, et al. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J. 1997;321:707-712.
19. Saad MJ, Folli F, Araki E, et al. Regulation of insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and dexamethasone. Mol Endocrinol. 1994;8:545-557.
20. Sakoda H, Ogihara T, Anai M, et al. Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes. 2000;49:1700-1708.
21. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
22. Ito T, Nakamura T, Fujimori N, et al. Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis. J Dig Dis. 2011;12(3):210-216.
23. Seino Y, Nanjo K, Tajima N, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int. 2010;1:2-20.
24. Kishitani Y. Clinical laboratory examination of diabetic patients in conjunction with metabolic syndrome [in Japanese]. Rinsho Byori. 2009;57:1066-1074.
25. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009;58:1504-1507.